Kankia, Ibrahim H ; Paramasivan, Poornima ; Elcombe, Matthew.. Kankia , I H , Paramasivan , P , Elcombe , M , Langdon , S P & Deeni , Y Y 2021 , ' Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors ' , Exploration of Targeted Anti-tumor Therapy , vol. 2 , no. 2 , pp. 187-203 . https://doi.org/10.37349/etat.2021.00040.
,
2021
Paramasivan, Poornima ; Kankia, Ibrahim H ; Langdon, Simon P. Paramasivan , P , Kankia , I H , Langdon , S P & Deeni , Y Y 2019 , ' Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies ' , Cancer Drug Resistance , vol. 2 , no. 3 , pp. 490-515 . https://doi.org/10.20517/cdr.2019.57.
,
2019
Khalil, Hilal S ; Langdon, Simon P ; Kankia, Ibrahim H.. Khalil , H S , Langdon , S P , Kankia , I H , Bown , J L & Deeni , Y Y 2016 , ' NRF2 regulates HER2 and HER3 signaling pathway to modulate sensitivity to targeted immunotherapies ' , Oxidative Medicine and Cellular Longevity , vol. 2106 , 4148791 . https://doi.org/10.1155/2016/4148791.
,
2016
